HK Stock Market Move | AK MEDICAL(01789) rose more than 9% after Yingerxi, the joint procurement driving the company's product demand is expected to increase the annual net profit by over 50% year-on-year.

AK MEDICAL (01789) rose more than 9% after Yingxi, at the time of writing, it has risen 8.87% to HK$4.91, with a trading volume of HK$177.068 million. On the news front, AK MEDICAL issued an announcement, expecting an unaudited profit attributable to owners of the parent of about 1.82 billion yuan for the year ending December 31, 2024, representing a 50% increase over the year ending December 31, 2023. The announcement stated that the increase in profit attributable to owners of the parent is mainly due to the further acceleration of export substitution driven by the national centralized procurement policy, the continuous increase in demand for the group's products, and the increase in revenue from the group's products; through effective cost control measures, operating costs and administrative expenses are relatively stable.